 |
Osstem implant (photo = Yonhap news) |
[Alpha Biz= Reporter Kim Jisun] The Securities and Futures Commission under the Financial Services Commission said on November 11 that it recommended Osstem Implant to dismiss its CEO.
According to the Securities and Futures Commission, Osstem Implant sold shares with company funds in September 2020, resulting in a loss of 15.131 billion won, but omitted related accounting.
In addition, a total of 90 billion won worth of embezzlement occurred in the second and third quarters of 2021, but financial statements were prepared and disclosed with cash and cashable assets. He also refused to submit the data without justifiable reasons.
In response, the Securities and Futures Commission voted on fines, recommendations for dismissal of the CEO, notification of the prosecution (violation of accounting and refusal to submit data), and correction orders. In addition, the Securities and Futures Commission imposed restrictions on audit work on Seohyun Accounting Corporation and its accountants.
AlphaBIZ Kim Jisun(stockmk2020@alphabiz.co.kr)
